Hofseth BioCare ASA (OSL:HBC)
1.345
+0.030 (2.28%)
Aug 4, 2026, 4:25 PM CET
Hofseth BioCare ASA Balance Sheet
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 49.11 | 67.05 | 25.58 | 23.89 | 32.43 | 49.92 |
Cash & Short-Term Investments | 49.11 | 67.05 | 25.58 | 23.89 | 32.43 | 49.92 |
Cash Growth | -31.74% | 162.15% | 7.06% | -26.33% | -35.04% | -71.12% |
Accounts Receivable | 19.88 | 21.52 | 18.85 | 14.85 | 14.07 | 10.09 |
Inventory | 60.39 | 59.83 | 55.92 | 82.54 | 116.53 | 90.81 |
Other Current Assets | 6.98 | 13.4 | 11.72 | 9.72 | 12.72 | 19.49 |
Total Current Assets | 136.37 | 161.79 | 112.06 | 131 | 175.75 | 170.31 |
Net Property, Plant & Equipment | 149.88 | 243.89 | 231.71 | 275.34 | 277.16 | 306.17 |
Other Intangible Assets | 35.01 | 73 | 84.86 | 110.57 | 121.18 | 106.11 |
Long-Term Investments | 48.06 | 98.1 | 93.89 | 38.13 | 5.9 | 6.78 |
Total Assets | 369.33 | 394.27 | 339.42 | 390.12 | 411.03 | 415.97 |
Accounts Payable | 108.47 | 94.62 | 93.63 | 55.16 | 145.75 | 124.17 |
Short-Term Debt | 133.87 | - | - | - | - | - |
Current Portion of Long-Term Debt | - | 56.53 | 48.02 | 28.35 | 0.54 | 2.42 |
Current Portion of Leases | - | 15.66 | 11.22 | 10.79 | 12.86 | 12.1 |
Other Current Liabilities | 19.06 | 74.41 | 15.56 | 157.03 | 13.08 | 12.25 |
Total Current Liabilities | 261.39 | 241.22 | 168.42 | 251.88 | 172.23 | 150.93 |
Long-Term Debt | 219.41 | 139 | 25.1 | 0.27 | 0.81 | 23.79 |
Long-Term Leases | - | 89.59 | 86.54 | 96.83 | 89.96 | 100.88 |
Total Long-Term Liabilities | 219.41 | 228.59 | 111.64 | 97.1 | 90.77 | 124.66 |
Total Liabilities | 480.8 | 469.81 | 280.07 | 348.98 | 263 | 275.6 |
Common Stock | 4.11 | 4.11 | 4.11 | 3.95 | 3.95 | 3.58 |
Additional Paid-in Capital | - | 4.11 | 115.98 | 79.7 | 293.48 | 278.55 |
Retained Earnings | -114.9 | -78.96 | 0 | - | 0 | 0 |
Minority Interest | -0.69 | -0.69 | -0.69 | -0.69 | -0.69 | -0.69 |
Shareholders' Equity | -111.48 | -75.53 | 59.36 | 41.14 | 148.03 | 140.38 |
Total Liabilities & Equity | 369.33 | 394.27 | 339.42 | 390.12 | 411.03 | 415.97 |
Total Debt | 353.28 | 300.78 | 170.88 | 136.25 | 104.17 | 139.18 |
Net Cash (Debt) | -304.17 | -233.73 | -145.3 | -112.36 | -71.74 | -89.26 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.73 | -0.55 | -0.35 | -0.28 | -0.19 | -0.25 |
Book Value | -111.48 | -75.53 | 59.36 | 41.14 | 148.03 | 140.38 |
Book Value Per Share | -0.27 | -0.18 | 0.14 | 0.10 | 0.40 | 0.39 |
Tangible Book Value | -146.49 | -148.53 | -25.5 | -69.43 | 26.85 | 34.27 |
Tangible Book Value Per Share | -0.35 | -0.35 | -0.06 | -0.18 | 0.07 | 0.10 |